These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15291687)

  • 21. How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting.
    Suzuki T; Uchida H; Watanabe K; Nomura K; Takeuchi H; Tomita M; Tsunoda K; Nio S; Den R; Manki H; Tanabe A; Yagi G; Kashima H
    Psychopharmacology (Berl); 2007 Dec; 195(2):285-95. PubMed ID: 17701027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One-year, randomized, open trial comparing olanzapine, quetiapine, risperidone and ziprasidone effectiveness in antipsychotic-naive patients with a first-episode psychosis.
    San L; Arranz B; Perez V; Safont G; Corripio I; Ramirez N; Dueñas R; Alvarez E
    Psychiatry Res; 2012 Dec; 200(2-3):693-701. PubMed ID: 22954905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
    Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
    J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurocognitive effectiveness of quetiapine, olanzapine, risperidone, and ziprasidone: a pragmatic, randomized trial.
    Johnsen E; Jørgensen HA; Kroken RA; Løberg EM
    Eur Psychiatry; 2013 Mar; 28(3):174-84. PubMed ID: 22153730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study.
    Johnsen E; Sinkeviciute I; Løberg EM; Kroken RA; Hugdahl K; Jørgensen HA
    BMC Psychiatry; 2013 Sep; 13():241. PubMed ID: 24079855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium.
    Yoon HJ; Park KM; Choi WJ; Choi SH; Park JY; Kim JJ; Seok JH
    BMC Psychiatry; 2013 Sep; 13():240. PubMed ID: 24074357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder.
    Lorenz RA; Jackson CW; Saitz M
    Pharmacotherapy; 2010 Sep; 30(9):942-51. PubMed ID: 20795849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
    Stroup TS; Lieberman JA; McEvoy JP; Swartz MS; Davis SM; Capuano GA; Rosenheck RA; Keefe RS; Miller AL; Belz I; Hsiao JK;
    Am J Psychiatry; 2007 Mar; 164(3):415-27. PubMed ID: 17329466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trial.
    Ramsey TL; Brennan MD
    Schizophr Res; 2014 Dec; 160(1-3):73-9. PubMed ID: 25449714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial.
    Sacchetti E; Valsecchi P; Parrinello G;
    Schizophr Res; 2008 Jan; 98(1-3):55-65. PubMed ID: 17933497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials.
    Stauffer V; Ascher-Svanum H; Liu L; Ball T; Conley R
    BMC Psychiatry; 2009 Mar; 9():13. PubMed ID: 19335905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second-generation antipsychotics in major depressive disorder: update and clinical perspective.
    Chen J; Gao K; Kemp DE
    Curr Opin Psychiatry; 2011 Jan; 24(1):10-7. PubMed ID: 21088586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical antipsychotics in the management of delirium: a review of the empirical literature.
    Boettger S; Breitbart W
    Palliat Support Care; 2005 Sep; 3(3):227-37. PubMed ID: 16594462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What CATIE found: results from the schizophrenia trial.
    Swartz MS; Stroup TS; McEvoy JP; Davis SM; Rosenheck RA; Keefe RS; Hsiao JK; Lieberman JA
    Psychiatr Serv; 2008 May; 59(5):500-6. PubMed ID: 18451005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study.
    Alptekin K; Hafez J; Brook S; Akkaya C; Tzebelikos E; Ucok A; El Tallawy H; Danaci AE; Lowe W; Karayal ON
    Int Clin Psychopharmacol; 2009 Sep; 24(5):229-38. PubMed ID: 19531959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost analysis of the treatment of schizophrenia in Thailand: a simulation model comparing olanzapine, risperidone, quetiapine, ziprasidone and haloperidol.
    Kongsakon R; Leelahanaj T; Price N; Birinyi-Strachan L; Davey P
    J Med Assoc Thai; 2005 Sep; 88(9):1267-77. PubMed ID: 16536115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder.
    Taneja C; Papakostas GI; Jing Y; Baker RA; Forbes RA; Oster G
    Ann Pharmacother; 2012 May; 46(5):642-9. PubMed ID: 22550279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
    Rocca P; Marino F; Montemagni C; Perrone D; Bogetto F
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):622-9. PubMed ID: 18081622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics.
    Gianfrancesco FD; Rajagopalan K; Sajatovic M; Wang RH
    J Clin Psychiatry; 2006 Feb; 67(2):222-32. PubMed ID: 16566617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical antipsychotics: newer options for mania and maintenance therapy.
    Vieta E; Goikolea JM
    Bipolar Disord; 2005; 7 Suppl 4():21-33. PubMed ID: 15948764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.